Patents by Inventor Michael Farber

Michael Farber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8588089
    Abstract: A mechanism for controlling resources and/or settings of an access network element like a base station is provided which allows an autonomous reconfiguration of, for example, the antenna configuration based on a set of performance indicators in a base station. The base station can reconfigure itself without the need of operator control so that during periods with low capacity demands the base station will reconfigure correspondingly, which may include a reduction of active cells by turning off the power for a part of the installed equipment.
    Type: Grant
    Filed: March 18, 2009
    Date of Patent: November 19, 2013
    Assignee: Nokia Siemens Networks Oy
    Inventors: Martin Döttling, Michael Färber, Andreas Lobinger, Jürgen Michel, Bernhard Raaf, Ingo Viering
  • Publication number: 20130287866
    Abstract: Use of nitric oxide amino acid esters for improving vascular circulation, and prophylaxis or treatment of a condition associated with impaired blood circulation, such as peripheral vascular disease. The nitric oxide amino acid esters may be co-administered with an antimicrobial in topical or transdermal compositions for improving vascular circulation, and prophylaxis or treatment of a condition associated with impaired blood circulation.
    Type: Application
    Filed: October 26, 2011
    Publication date: October 31, 2013
    Applicant: ORAL DELIVERY TECHNOLOGY LTD.
    Inventor: Michael Farber
  • Publication number: 20120289597
    Abstract: There is provided a topical composition and a method for treating or alleviating pain in a patient in need thereof. The topical composition contain amino acid ester compounds comprising at least one nitric oxide releasing group and pharmaceutical salts thereof and a topical analgesic compound.
    Type: Application
    Filed: May 14, 2012
    Publication date: November 15, 2012
    Applicant: ORAL DELIVERY TECHNOLOGY LTD.
    Inventor: Michael FARBER
  • Patent number: 8229489
    Abstract: A radio communication system, for example a TDMA/CDMA radio communication system, has at least one base station recurringly offering frequency channels for a random access for mobile stations in an upstream direction. The mobile station that requests a connection setup measures a reception power of a signal sent in a downstream direction by the base station and sets a transmission power for sending an access radio block to the base station dependent on the measured reception power. A variable transmission power control can thus be implemented at the mobile station side with the assistance of the measured reception power of the signal transmitted on the part of the base station, being also capable of being implemented for random access of the mobile stations, this having previously always occurred with maximum transmission power.
    Type: Grant
    Filed: October 26, 1998
    Date of Patent: July 24, 2012
    Assignee: Siemens Aktiengesellschaft
    Inventors: Anja Klein, Michael Färber, Christian Lüders
  • Publication number: 20110195935
    Abstract: There is provided amino acid ester compounds comprising at least one nitric oxide releasing group, pharmaceutically acceptable salts thereof and compositions thereof. These compounds involve an amino acid side-chain or an amino acid derivative thereof and a nitric oxide releasing group as depicted in the following structures: wherein R1 is either an ethyl or an amino acid side-chain group or an amino acid derivative thereof and R2 is an amino acid side-chain group or an amino acid derivative thereof and n is an integer from 1 to 10.
    Type: Application
    Filed: September 24, 2009
    Publication date: August 11, 2011
    Inventor: Michael Farber
  • Publication number: 20110096687
    Abstract: A mechanism for controlling resources and/or settings of an access network element like a base station is provided which allows an autonomous reconfiguration of, for example, the antenna configuration based on a set of performance indicators in a base station. The base station can reconfigure itself without the need of operator control so that during periods with low capacity demands the base station will reconfigure correspondingly, which may include a reduction of active cells by turning off the power for a part of the installed equipment.
    Type: Application
    Filed: March 18, 2009
    Publication date: April 28, 2011
    Inventors: Martin Döttling, Michael Färber, Andreas Lobinger, Jürgen Michel, Bernhard Raaf, Ingo Viering
  • Publication number: 20110092167
    Abstract: It is disclosed a method including creating inquiry information related to an evaluation of at least one network terminal, and transmitting the created inquiry information in a long-range reference signal; a method including receiving the inquiry information in the long-range signal, establishing, based on the received inquiry information, report information related to a quality of the long-range reference signal, and transmitting the established report information; and a method including receiving the report information, and evaluating, based on the received report information, at least one network terminal.
    Type: Application
    Filed: April 14, 2009
    Publication date: April 21, 2011
    Inventors: Martin Döttling, Michael Färber, Andreas Lobinger, Jürgen Michel, Bernhard Raaf, Ingo Viering
  • Publication number: 20100311780
    Abstract: There is provided novel amino acid ester compounds comprising at least one nitric oxide releasing group and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one amino acid ester compound comprising at least one nitric oxide releasing group, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent. Also provided are compositions for increasing nitric oxide physiological levels in a subject, methods for increasing nitric oxide physiological levels in a subject, methods for improving a subject's muscle strength, athletic performances and/or lean body mass gain and or performance in a subject.
    Type: Application
    Filed: August 13, 2010
    Publication date: December 9, 2010
    Applicant: Oral Delivery Technology LTD.
    Inventor: Michael Farber
  • Publication number: 20100303937
    Abstract: The present invention relates to a composition for increasing testosterone physiological levels comprising: a) a sufficient amount of at least one aromatase inhibitor chosen from a flavone substituted with at least one methoxy group at position 3?,4?,5 or 7, any combinations thereof, and any di, tri or tetra combinations thereof; and a flavanone substituted with at least one methoxy group at position 3?,4?,5 or 7, any combinations thereof, and any di, tri or tetra combinations thereof; and b) a sufficient amount of at least one 5?-reductase inhibitor that inhibit testosterone conversion to DHT, such as beta-sitosterols; in association with a pharmaceutically acceptable carrier.
    Type: Application
    Filed: May 31, 2010
    Publication date: December 2, 2010
    Inventor: Michael FARBER
  • Patent number: 7807716
    Abstract: There is provided novel amino acid ester compounds comprising at least one nitric oxide releasing group and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one amino acid ester compound comprising at least one nitric oxide releasing group, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent. Also provided are compositions for increasing nitric oxide physiological levels in a subject, methods for increasing nitric oxide physiological levels in a subject, methods for improving a subject's muscle strength, athletic performances and/or lean body mass gain and or performance in a subject.
    Type: Grant
    Filed: September 23, 2009
    Date of Patent: October 5, 2010
    Assignee: Oral Delivery Technology Ltd.
    Inventor: Michael Farber
  • Publication number: 20100076043
    Abstract: There is provided novel amino acid ester compounds comprising at least one nitric oxide releasing group and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one amino acid ester compound comprising at least one nitric oxide releasing group, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent. Also provided are compositions for increasing nitric oxide physiological levels in a subject, methods for increasing nitric oxide physiological levels in a subject, methods for improving a subject's muscle strength, athletic performances and/or lean body mass gain and or performance in a subject.
    Type: Application
    Filed: September 23, 2009
    Publication date: March 25, 2010
    Applicant: Oral Delivery Technology Ltd.
    Inventor: Michael Farber
  • Publication number: 20090275356
    Abstract: A method of controlling interference between adjacent communication systems (1, 2) each of which operates in a predetermined frequency band. The method comprises reducing transmit power levels at frequencies (13, 14) at each end (10, 11) of the frequency band (12) and maintaining power levels at other frequencies (15) of the frequency bands (12), such that interference with frequencies at an end of the frequency band of an adjacent system is reduced.
    Type: Application
    Filed: December 13, 2006
    Publication date: November 5, 2009
    Inventors: Thomas Malcolm Chapman, Michael Farber
  • Publication number: 20090239569
    Abstract: A method for changing a downlink transmission power level can include receiving information about interference noise. When the interference noise satisfied a predefined level, the downlink transmission power level can be changed. Typically, the transmission power level can be decreased when the interference noise is above a predefined value. The transmission power level change can be coordinated (e.g. coordination in terms of power step size, in terms of frequency portion to which the power change is applied and in terms of time when to apply the transmission power change) with transmission power level changes in other cells. Also, interferences levels may be reassessed following the first transmission power change and the power levels are changes a second time. Optionally, only a portion of the transmission bandwidth is changed or only specific DL physical channels are considered.
    Type: Application
    Filed: March 18, 2009
    Publication date: September 24, 2009
    Inventors: Martin Dottling, Michael Farber, Andreas Lobinger, Jurgen Michel, Bernhard Raaf
  • Publication number: 20090209263
    Abstract: A method controls a radio cell monitoring system. A standardized radio cell list is transmitted by a device on the network side, the device being allocated to a radio cell of interest. The radio cell list lists radio cells that are adjacent to the radio cell of interest, receiving radio communication terminals monitoring, using the radio cellist, the signals of the adjacent radio cells for a handover or a cell reselection by way of measurement. The respective measurements of the radio communication terminals are transmitted to the device on the network end. At least one priority on the network side is allocated to each radio cell of the radio cell list. Additionally, at least one indication on the network side, indicating which services are offered within the respective radio cell for execution, is allocated to every radio cell of the radio cell list.
    Type: Application
    Filed: April 27, 2007
    Publication date: August 20, 2009
    Inventors: Volkerö Breuer, Michael Färber, Frank Lamprecht
  • Publication number: 20090180406
    Abstract: Interference is reduced between two radio communication systems. A first radio communication system uses a first and a second frequency ranges which are separated by a duplex gap. A second radio communication system uses a third radio frequency range which forms part of the duplex gap. The first and second radio communication systems exchange information in order to establish an a priori knowledge about a connection on the network side. The a priori knowledge includes the radio transmission resources of the first frequency range provided on the radio communication system side and of the second frequency range and the radio transmission resources of the third frequency range (FB3) desired for call setup and completion. Radio transmission resources are selected depending on the a priori knowledge at the second radio communication system in order to reduce interferences between the first and second radio communication systems.
    Type: Application
    Filed: April 27, 2007
    Publication date: July 16, 2009
    Inventors: Volker Breuer, Michael Färber
  • Publication number: 20090163205
    Abstract: In a wireless communication system having at least first and second radio stations located at a network end and connected to a core network, the first radio station receives a registration message from a user station to initially register the user station in a radio station located at the network end, after the user station has been switched on. Subsequently, communication takes place between the core network and the user station. Signaling messages that are to be sent from the core network to the user station are transmitted, at least at the beginning of the communication between the core network and the user station, from the core network to the second radio station, then from the second radio station to the first radio station or another radio station located at the network end, and from the first radio station (or the other radio station) directly to the user station.
    Type: Application
    Filed: November 24, 2006
    Publication date: June 25, 2009
    Applicant: Siemens Aktiengesellschaft
    Inventors: Michael Färber, Norbert Kroth
  • Patent number: 7531192
    Abstract: The present invention provides oral delivery systems for functional ingredients, such as drugs, nutritional supplements, botanicals, and vitamins. The delivery systems comprise an ingestible matrix within which the functional ingredient(s) are substantially uniformly and completely dispersed and in which degradation of the functional ingredient(s) is minimised. The matrix comprises 1) one or more carbohydrate; 2) one or more sugar, sugar syrup and/or sugar alcohol; 3) one or more hydrocolloid; 4) one or more polyhydric alcohol; 5) one or more source of mono- or divalent cations, and 5) water. The combination of carbohydrate and hydrocolloid in the matrix ensures that the delivery system readily retains the solvent component and thereby prevents separation of the solvent from other components of the matrix. The invention also provides methods of preparing and using the delivery systems.
    Type: Grant
    Filed: April 21, 2005
    Date of Patent: May 12, 2009
    Assignee: 2120812 Ontario Inc.
    Inventors: Michael Farber, Jonathan Farber
  • Publication number: 20090017107
    Abstract: The present invention relates to a composition for increasing testosterone physiological levels comprising a sufficient amount of at least two ketosteroid derivatives of testosterone metabolism in association with a liposomal carrier bound to a saliva-absorbing carrier, wherein said increase in testosterone levels increases libido.
    Type: Application
    Filed: July 14, 2008
    Publication date: January 15, 2009
    Applicant: ORAL DELIVERY TECHNOLOGY LTD.
    Inventor: Michael Farber
  • Publication number: 20090018107
    Abstract: The present invention relates to a composition for increasing testosterone physiological levels comprising a sufficient amount of at least two ketosteroid derivatives of testosterone metabolism in association with a liposomal carrier bound to a saliva-absorbing carrier for increasing testosterone physiological levels.
    Type: Application
    Filed: July 14, 2008
    Publication date: January 15, 2009
    Applicant: ORAL DELIVERY TECHNOLOGY LTD.
    Inventor: Michael FARBER
  • Patent number: 7333775
    Abstract: A method detects which radio communication terminals use interference suppression procedures, in a radio communication system. Here radio communication terminals periodically return measurement signals which represent radio field characteristics and/or reception situations determined at the radio terminal to a base station and compare these signals with one another and also with threshold values determined on the base station side. The comparisons conducted are used for assigning radio communication terminals to groups, with a first group being assigned those radio communication terminals which display a good reception situation during the threshold value comparison, whereas a second group is assigned all further radio communication terminals.
    Type: Grant
    Filed: April 29, 2004
    Date of Patent: February 19, 2008
    Assignee: Siemens Aktiengesellschaft
    Inventors: Carsten Ball, Michael Färber